|
× |
 |
A Pilot Study of Barriers to Medication Adherence in Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychocutaneous Medicine in Iraq: Current Status and Recommendations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Camptocormia and Antipsychotic Medications PDF |
$40.00 |
|
$40.00 |
|
× |
|
Factors Differentiating Childhood-Onset and Adolescent-Onset Schizophrenia: A Claims Database Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Medication Treatment for the Severely and Persistently Mentally Ill: The Texas Medication Algorithm Project PDF |
$40.00 |
|
$40.00 |
|
× |
|
Delusional Misidentification Post–Traumatic Brain Injury Responding to Clozapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Lamotrigine Treatment of Pathologic Skin Picking: An Open-Label Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
When Nothing Stops Catatonia Except Electroconvulsive Therapy and Maybe A New Savior, Clozapine PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Association Between the Inflammatory Biomarker GlycA and Depressive Symptom Severity PDF |
$40.00 |
|
$40.00 |
|
× |
|
Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective PDF |
$40.00 |
|
$40.00 |
|
× |
|
Polyneuropathy and Myopathy in Anorexia Nervosa PDF |
$40.00 |
|
$40.00 |
|
× |
|
Quality Indicators in Community Mental Health Services: A Scoping Review PDF |
$40.00 |
|
$40.00 |
|
× |
|
Residual Symptoms in Depression: Can Treatment Be Symptom-Specific? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antecedents to Panic Disorder in Nonreferred Adults. PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk Factors for Antidepressant-Related Switch to Mania PDF |
$40.00 |
|
$40.00 |
|
× |
|
Severe Psychosis Due to Cushing Syndrome PDF |
$40.00 |
|
$40.00 |
|
|